You are here

05-03-2020 | © istockphot.com | Doucefleur
Historically, due to a difference in lifestyles, men were at a higher risk of suffering from a heart attack or stroke than women. While this is no longer the case, obsolete stereotypes and misconceptions mean these conditions in women are often misdiagnosed. ERC grantee Nabila Bouatia-Naji aims to decipher the genetic and molecular causes of two devastating cardiovascular diseases which commonly affect women under 60. Her work could lead to a better understanding of these diseases and to improvements in treatment.
03-12-2019 | @ Shutterstock
The ASTAOMEGA project solves the problems linked to the production of omega-3 and antioxidants at the same time. The team promises higher production rates and improved sustainability at a lower cost.
27-09-2019 | Wiley online library
About the size of a big cherry, the first-of-its-kind 3D printed heart has cells, blood vessels, ventricles and chambers. This feat is the work of Prof. Tal Dvir and his team at Tel Aviv University. They managed to engineer such miniature organs using cells and biological materials that are originated from human patients. Besides the remarkable technical achievement, this breakthrough could potentially be the answer to the shortage of organ donors in the future.
27-08-2018 | © picture
At the forefront of medicine, gene therapy is based on the insertion of genes into an individual's cells and tissues to treat a disease. Scientists are currently testing several approaches to this experimental technique. One of them, Prof. Seppo Ylä-Herttuala, intends to develop a novel method to treat myocardial ischemia by activating endogenous genes to propel angiogenesis. If successful, he will open a new era in gene therapy.
20-08-2018 | iStock
More than 100 million people worldwide suffer from valvular heart disease, affecting one or more of the heart’s four valves and causing breathlessness, chest pain, dizziness and fainting. If severe valvular heart disease is not properly treated, chances of surviving decrease, especially in the elderly. The only effective therapy is heart valve replacement, which may entail some risks and lead to revision surgeries. What can be done to improve safety and durability of artificial heart valves? 
25-08-2016 | © picture
More than 3.5 million new people are diagnosed with heart failure every year in Europe, with a long-term prognosis of 50% mortality within four years. There is urgent need for more innovative, regenerative therapies with the potential to change the course of the condition.
20-07-2016 | © picture
Cardiovascular diseases (CVD) are a major cause of morbidity and mortality in Europe. Prevention relies on measuring traditional risk factors such as age, gender, hypertension, diabetes, hypercholesterolemia and smoking. However, many individuals, apparently at low-risk, still develop CVD. Improving predictions beyond the traditional risk factors is the challenge undertaken by Prof. Olle Melander.
19-05-2015 | Portrait: © Academy of Medical Science
Prof. Michael Schneider is a leading authority in the field of cardiac molecular biology. In 2008, he obtained an ERC grant to identify the mechanisms governing self-renewal of cardiac progenitor cells, a population of stem cells located in the heart itself that might be exploited to play a key role in regenerating this vulnerable organ in heart disease. With his team at Imperial College London, he has now identified a stem cell injection that could mend broken hearts, a discovery in the field of regenerative medicine published this week in Nature Communications.
28-09-2012 | © Mathcard project
Mathematics might seem like an abstract discipline, remote from real-world applications but their equations can significantly help understand and simulate the functioning of nature. Professor Alfio Quarteroni of the École Polytechnique Fédérale de Lausanne (EPFL, Switzerland) is leading the Mathcard project in developing mathematical models of the blood flow in our cardiovascular system. On the occasion of World Heart Day, he explains how his project could help surgeons and save lives.